{"id":"F2007B01031","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 1 of 2001)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2001","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":62491,"registerId":"commonwealth-F2007B01031-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 1 of 2001)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 1 of 2001\n\nI, ALAN WILLIAM STEVENS, Acting Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Aged Care and Delegate of the Minister for Health and Aged Care, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1.  This Declaration commences on 1 February 2001.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nDesipramine Hydrochloride\n\nFerrous Sulfate – Dried\n\nMedrysone\n\nPrednisolone Acetate\n\nDated this 4th day of January 2001.\n\nALAN WILLIAM STEVENS\n\nActing Assistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Aged Care\n\nDelegate of the Minister for Health and Aged Care","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1239},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This declaration performs exactly the narrow function authorised by section 85(2AA) of the National Health Act 1953: removing specified pharmaceutical benefits from the PBS schedule. It has not expanded beyond the original statutory purpose of managing the PBS formulary."},"complexity_factors":["Extremely short document (only 4 operative sections)","No defined terms or interpretation section","Simple, unqualified legal effect (delisting specific items by name)","Minimal cross-referencing (only cites authority provisions in parent Act)","No conditional logic, exceptions, or procedural requirements"],"plain_english_summary":"This instrument removes four specific medicines—desipramine hydrochloride, ferrous sulfate (dried), medrysone and prednisolone acetate—from Australia’s Pharmaceutical Benefits Scheme, so from 1 February 2001 patients must pay full commercial prices instead of PBS-subsidised rates. \n\nThe change, made by a senior Health Department delegate acting for the Minister, followed advice from the Pharmaceutical Benefits Advisory Committee and may push patients and prescribers toward alternative PBS-listed treatments."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2001","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2001/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2001/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2001/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2001/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-1-of-2001/documents"}}